Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Botulinum toxin A on Postherpetic Neuralgia
IRCT138812033396N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of botulinum toxin type A in postherpetic neuralgia (PHN), sponsored by Shiraz University of Medical Sciences. Started Jan 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on IRCT138812033396N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138812033396N1.